Browse By: Country ι Category ι Latest Reports ι Tag

Hepatitis Market Research Reports

Hepatitis C Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
Hepatitis is defined as the inflammation of the liver due to an infection by a virus or other causative organism or toxin. Hepatitis C on the other hand, is primarily as a result of the infection by hepatitis C virus (HCV). With a cure rate between 50%-80%, and no commercially available vaccine as of yet, hepatitis C is considered a deadly disease with a moderate to high infection rate. It is the leading cause for liver transplantation in the U.K and North America.  The transmission of this virus in a majority occurs from injectables drug abuse, as the virus can only be transmitted via blood-to-blood contact. The secondary transmission factors include tattooing, sexual contact, healthcare (blood transfusion, organ transplant) mishaps, and other rare unknown cases. HIV infected indi
Published Date: Apr 2025
Published By: Transparency

Price: $5795
Hepatitis Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period. It can be caused by a group of viruses called as hepatitis viruses which include groups A, B, C, D, and E. The most observed types of this disease are hepatitis A, hepatitis B and hepatitis C. Globally, 350 million people are chronically infected with any one form of hepatitis and around 500,000 people die every year according to World Health Organization. Hepatitis A is a simpler form of which does not lead to chronic infections. Patients suffering from hepatitis A recover within two mont
Published Date: Nov 2020
Published By: Transparency

Price: $5795
United States Hepatitis Drugs Market Report 2017
Sales, means the sales volume of Hepatitis Drugs Revenue, means the sales value of Hepatitis Drugs This report studies sales (consumption) of Hepatitis Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering F. Hoffmann-La Roche Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Novartis Vertex Pharmaceuticals Abbvie Achillion Pharmaceuticals Bristol-Myers Squibb Dynavax Technologies Mitsubishi Tanabe Pharma Market Segment by States, covering California Texas New York Florida Illinois Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Oral Injection Split by applications,
Published Date: Jan 2017
Published By: QYResearch

Price: $3800
China Hepatitis Drugs Market Research Report 2017
This report studies Hepatitis Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer.
Published Date: Jan 2017
Published By: QYResearch

Price: $3200
Europe Hepatitis Drugs Market Report 2017
This report studies sales (consumption) of Hepatitis Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries,
Published Date: Jan 2017
Published By: QYResearch

Price: $3900
Global Hepatitis Drugs Sales Market Report 2017
This report studies sales (consumption) of Hepatitis Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions,
Published Date: Jan 2017
Published By: QYResearch

Price: $4000
Global Hepatitis Drugs Market Professional Survey Report 2017
Production, means the output of Hepatitis Drugs Revenue, means the sales value of Hepatitis Drugs This report studies Hepatitis Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering F. Hoffmann-La Roche Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Novartis Vertex Pharmaceuticals Abbvie Achillion Pharmaceuticals Bristol-Myers Squibb Dynavax Technologies Mitsubishi Tanabe Pharma By types, the market can be split into Oral In
Published Date: Jan 2017
Published By: QYResearch

Price: $3500
Global Hepatitis Drugs Market Research Report 2017
Production, means the output of Hepatitis Drugs Revenue, means the sales value of Hepatitis Drugs This report studies Hepatitis Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering F. Hoffmann-La Roche Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Novartis Vertex Pharmaceuticals Abbvie Achillion Pharmaceuticals Bristol-Myers Squibb Dynavax Technologies Mitsubishi Tanabe Pharma Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Hepatitis Drugs in these
Published Date: Jan 2017
Published By: QYResearch

Price: $2900
Nonalcoholic Steatohepatitis (NASH)- Epidemiology Forecast To 2023
Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication. Scope of the Report • The Report includes the prevalent population and how will it change over the next eight years. • Prevalent or incident cases segmented by age and sex. • Coverage of key Nonalcoholic Steatohepatitis (NASH) subpopulations and its prevalent or incident cases • The key differences in epidemiology patterns across the seven market segments Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Nonalcoholic Steatohepatitis (NASH) market. • Identifying prevalent patient populat
Published Date: Jan 2017
Published By: DelveInsight

Price: $2750
Nonalcoholic Steatohepatitis (NASH)- Market Insights, Epidemiology and Market Forecast-2023
DelveInsight’s Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Nonalcoholic Steatohepatitis (NASH) for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Nonalcoholic Steatohepatitis (NASH) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Nonalcoholic Steatohepatitis (NASH) till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the
Published Date: Jan 2017
Published By: DelveInsight

Price: $4950
Hepatitis-API Insights, 2017
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hepatitis C Report is to understand the market and pipeline status of the drugs around the Hepatitis C to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hepatitis C. While the leading brands, companies
Published Date: Jan 2017
Published By: DelveInsight

Price: $2000
Hepatitis B-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Hepatitis B-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hepatitis B Report is to understand the market and pipeline status of the drugs around the Hepatitis B to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hepatitis B. While the leading brands, companies
Published Date: Jan 2017
Published By: DelveInsight

Price: $2000
Hepatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Hepatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hepatitis Report is to understand the market and pipeline status of the drugs around the Hepatitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hepatitis. While the leading brands, companies and che
Published Date: Jan 2017
Published By: DelveInsight

Price: $2000
Hepatitis C Virus (HCV) Protease Inhibitors-Pipeline Insights, 2017
DelveInsight’s, “Hepatitis C Virus (HCV) Protease Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis C Virus (HCV) Protease Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hepatitis C Virus (HCV) Protease Inhi
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Steatohepatitis-Pipeline Insights, 2017
DelveInsight’s, “ Steatohepatitis-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Steatohepatitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Steatohepatitis. DelveInsight’s Report also assesses the Steatohepatitis therapeutics by
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Non-Alcoholic Steatohepatitis-Pipeline Insights, 2017
DelveInsight’s, “ Non-Alcoholic Steatohepatitis-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Non-Alcoholic Steatohepatitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Non-Alcoholic Steatohepatitis. DelveInsight’s Report also ass
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Hepatitis D-Pipeline Insights, 2017
DelveInsight’s, “ Hepatitis D-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis D. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hepatitis D. DelveInsight’s Report also assesses the Hepatitis D therapeutics by Monotherapy, Co
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
Hepatitis A-Pipeline Insights, 2017
DelveInsight’s, “ Hepatitis A-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis A. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hepatitis A. DelveInsight’s Report also assesses the Hepatitis A therapeutics by Monotherapy, Co
Published Date: Jan 2017
Published By: DelveInsight

Price: $1250
United States Human Hepatitis B Immunoglobulin (IM) Market Report 2016
Sales, means the sales volume of Human Hepatitis B Immunoglobulin (IM) Revenue, means the sales value of Human Hepatitis B Immunoglobulin (IM) This report studies sales (consumption) of Human Hepatitis B Immunoglobulin (IM) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Baxter CSL Bayer Grifols Octapharma Shanghai RAAS Hualan Biological China Biologic Tiantan Biologic Shuanglin Bio-pharmacy Sichuan Yuanda Shuyang Boya Bio-pharmaceutical Shanghai Institute of Biological Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into 100IU/Bottle Human Hepatitis B Immunoglobulin (IM) 200IU/Bottle Human He
Published Date: Dec 2016
Published By: QYResearch

Price: $3800

Upcoming Reports

Wheelchair Accessible Vehicle Converters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Vehicles which are converted in a way that have easy access for wheelchairs are termed as wheelchair accessible vehicles or WAV’s. The vehicles are specially converted from a standard vehicle to WAV in order to accommodate the wheelchair. Wheelchair accessible vehicles are considered as mult
Published By: Transparency
Price: $5795
Enteral Nutrition Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Enteral nutrition pumps also known as enteral feeding pumps are used to deliver nutritious foods containing carbohydrate, protein, fat, vitamin, minerals and water by inserting directly into the stomach or parts of small intestine. Enteral nutrition pumps are recommended to patients suffering from
Published By: Transparency
Price: $5795
Residential Water Treatment Equipment Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2014 - 2020
Increasing industrial and environmental pollution around the world is increasing the need for water treatment. Water pollution due to increasing industrialization and environment pollution is leading to death and spread of diseases. It also adversely affects more than 1 billion of population every
Published By: Transparency
Price: $5795
Steam Boiler System Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
The growing need of effective heating systems as well as the requirement of increasing operating efficiency of residential and commercial complexes has led to the widespread adoption of steam boiler systems. This technology provides high steam temperature and improved pressure parameters to achiev
Published By: Transparency
Price: $5795
Seismic Survey Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
Increasing exploration activities owing to the efforts of oil and gas companies to locate new oil and gas reserves is expected to drive the global seismic survey market during the forecast period. Oil and gas companies use seismic surveys to map and interpret potential petroleum reserves.  P
Published By: Transparency
Price: $5795

Back To Top